OA05290A - Procédé de préparation d'une forme cristalline d'un antibiotique. - Google Patents

Procédé de préparation d'une forme cristalline d'un antibiotique.

Info

Publication number
OA05290A
OA05290A OA55785A OA55785A OA05290A OA 05290 A OA05290 A OA 05290A OA 55785 A OA55785 A OA 55785A OA 55785 A OA55785 A OA 55785A OA 05290 A OA05290 A OA 05290A
Authority
OA
OAPI
Prior art keywords
antibiotic
preparing
crystalline form
crystalline
Prior art date
Application number
OA55785A
Other languages
English (en)
French (fr)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of OA05290A publication Critical patent/OA05290A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
OA55785A 1975-04-11 1976-03-27 Procédé de préparation d'une forme cristalline d'un antibiotique. OA05290A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (1)

Publication Number Publication Date
OA05290A true OA05290A (fr) 1981-02-28

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
OA55785A OA05290A (fr) 1975-04-11 1976-03-27 Procédé de préparation d'une forme cristalline d'un antibiotique.

Country Status (31)

Country Link
US (1) US4006138A (xx)
JP (1) JPS51123812A (xx)
AR (1) AR210880A1 (xx)
AT (1) AT343806B (xx)
AU (1) AU500013B2 (xx)
BE (1) BE840179A (xx)
CA (1) CA1045114A (xx)
CH (1) CH621554A5 (xx)
CS (1) CS191970B2 (xx)
DD (1) DD125950A5 (xx)
DE (1) DE2614669C2 (xx)
DK (1) DK148022C (xx)
ES (1) ES446907A1 (xx)
FI (1) FI65069C (xx)
FR (1) FR2306698A1 (xx)
GB (1) GB1546898A (xx)
GR (1) GR59912B (xx)
HU (1) HU175592B (xx)
IL (1) IL49100A (xx)
LU (1) LU74740A1 (xx)
MX (1) MX3687E (xx)
NL (1) NL184258C (xx)
NO (1) NO151748C (xx)
OA (1) OA05290A (xx)
PL (1) PL104803B1 (xx)
PT (1) PT64917B (xx)
RO (1) RO68501A (xx)
SE (1) SE435290B (xx)
SU (1) SU668608A3 (xx)
YU (1) YU40643B (xx)
ZA (1) ZA761103B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
PT64917B (en) 1977-08-24
PL104803B1 (pl) 1979-09-29
ZA761103B (en) 1977-10-26
CA1045114A (en) 1978-12-26
FR2306698B1 (xx) 1979-10-05
NO151748C (no) 1985-06-05
CS191970B2 (en) 1979-07-31
JPS6110474B2 (xx) 1986-03-29
SU668608A3 (ru) 1979-06-15
AR210880A1 (es) 1977-09-30
DE2614669C2 (de) 1984-09-27
JPS51123812A (en) 1976-10-28
AU1143576A (en) 1977-09-01
NO761017L (xx) 1976-10-12
NL184258B (nl) 1989-01-02
YU79276A (en) 1982-10-31
IL49100A (en) 1979-03-12
YU40643B (en) 1986-04-30
FI65069B (fi) 1983-11-30
AT343806B (de) 1978-06-26
SE7602565L (sv) 1976-10-12
HU175592B (hu) 1980-09-28
IL49100A0 (en) 1976-04-30
DK148022B (da) 1985-02-04
GR59912B (en) 1978-03-20
ATA258476A (de) 1977-10-15
FI65069C (fi) 1984-03-12
PT64917A (en) 1976-04-01
FI760788A (xx) 1976-10-12
DD125950A5 (xx) 1977-06-01
NL7603660A (nl) 1976-10-13
FR2306698A1 (fr) 1976-11-05
DK148022C (da) 1985-07-22
BE840179A (fr) 1976-09-30
US4006138A (en) 1977-02-01
GB1546898A (en) 1979-05-31
CH621554A5 (xx) 1981-02-13
SE435290B (sv) 1984-09-17
DK150676A (da) 1976-10-12
AU500013B2 (en) 1979-05-10
MX3687E (es) 1981-04-29
DE2614669A1 (de) 1976-10-21
NL184258C (nl) 1989-06-01
ES446907A1 (es) 1977-09-16
RO68501A (ro) 1981-04-30
NO151748B (no) 1985-02-18
LU74740A1 (xx) 1976-11-11

Similar Documents

Publication Publication Date Title
LU79547A1 (fr) Procede de preparation de nouvelles compositions antibiotiques a base d'une tetracycline
YU38476A (en) Process for producing beta-lactam compounds
ZA763840B (en) Process for the manufacture of planographic printing form
HU175186B (hu) Sposob poluchenija novykh proizvodnykh eritromicina
YU126076A (en) Process for producing n-perfluoroacyl)-n-phosphonomethyl-glycine compounds
OA05290A (fr) Procédé de préparation d'une forme cristalline d'un antibiotique.
OA04809A (fr) Procédé de préparation d'a-aminoacyl-3-halocépha-losporines.
JPS51148725A (en) Process for producing 1*44diaminoanthraquinonee2*33 dinitril
BE841285A (fr) Procede de preparation d'acetoacetyl-arylamides
OA05405A (fr) Procédé de préparation de composés pharmacologiquement actifs.
FR2314192A1 (fr) Procede de preparation d'oxaphospholannes-1,2
RO69709A (ro) Procedeu pentru prepararea unei forme cristaline metanolate a 7-(d-2-hidroxi-2-fenilacetamido)-3-(1-metil-1h-tetrazol-5-iltiometil)-3-cefem-4-carboxilatului de sodiu
OA05404A (fr) Procédé de préparation de composés pharmocologiquement actifs.
OA05241A (fr) Procédé de préparation d'E-(-glutamyl)-lysine.
JPS5225759A (en) Process for preparing 4*44dihydroxyy 3*3**5*5**tetraalkylldiphenyl alkane
FR2315273A1 (fr) Procede de preparation d'indoloquinolizines
OA05675A (fr) Procédé de préparation de dérivés de méthylamine.
EG12277A (en) Process for preparing of 1-acyl-1,2,3,4 tetrahydro-6-quinolinols compounds
FR2307781A1 (fr) Procede de preparation d'acenaphtenes
HU179013B (en) Process for producing antibiotic composition of a-35 512
FR2309490A1 (fr) Procede de preparation d'une composition d'alumine-beta
FR2334654A1 (fr) Procede de preparation d'halogeno-nitrobenzenes
OA05696A (fr) Procédé de préparation d'un dérivé d'acétonitrile et dérivé obtenu par ce procédé.
OA05694A (fr) Nouveau procédé de préparation d'un dérivé de l'acétamide et dérivé obtenu par ce procédé.
FR2317307A1 (fr) Procede de preparation d'oxaphospholannes-1,2